Cresset Asset Management LLC Sells 20,567 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cresset Asset Management LLC trimmed its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 64.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 11,460 shares of the medical instruments supplier’s stock after selling 20,567 shares during the quarter. Cresset Asset Management LLC’s holdings in DENTSPLY SIRONA were worth $219,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Riverview Trust Co bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB lifted its position in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 1,232 shares during the last quarter. UMB Bank n.a. lifted its position in shares of DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 1,568 shares during the last quarter. Finally, Quarry LP lifted its position in shares of DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after buying an additional 780 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on XRAY. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Barrington Research upped their price objective on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Monday, May 12th. Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Finally, Morgan Stanley cut DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price for the company. in a report on Tuesday, April 15th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.36.

DENTSPLY SIRONA Trading Up 1.2%

Shares of XRAY stock opened at $16.70 on Monday. The stock has a market cap of $3.33 billion, a price-to-earnings ratio of -8.07, a PEG ratio of 1.80 and a beta of 0.92. The stock has a 50-day moving average of $14.41 and a 200-day moving average of $17.30. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $28.44.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million during the quarter, compared to analysts’ expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s quarterly revenue was down 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.42 earnings per share. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.83%. DENTSPLY SIRONA’s dividend payout ratio is currently -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.